• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Claudin-18 基因结构、调控和表达在哺乳动物中具有进化保守性。

Claudin-18 gene structure, regulation, and expression is evolutionary conserved in mammals.

机构信息

Ganymed Pharmaceuticals AG, Freiligrathstr. Mainz, Germany.

出版信息

Gene. 2011 Aug 1;481(2):83-92. doi: 10.1016/j.gene.2011.04.007. Epub 2011 May 4.

DOI:10.1016/j.gene.2011.04.007
PMID:21571049
Abstract

Claudin-18 isoform 2 (CLDN18.2) is one of the few members of the human claudin family of tight junction molecules with strict restriction to one cell lineage. The objective of the current study was to compare molecular structure and tissue distribution of this gastrocyte specific molecule in mammals. We show here that the CLDN18.2 protein sequence is highly conserved, in particular with regard to functionally relevant domains in mouse, rat, rabbit, dog, monkey and human and also in lizards. Moreover, promoter regions of orthologs are highly homologous, including the binding site of the transcription factor cyclic AMP-responsive element binding protein (CREB), which is known to regulate activation of human CLDN18.2. Employing RT-PCR and immunohistochemistry, we found that, analogous to the human gene, all orthologous CLDN18.2 transcripts and proteins are exclusively expressed in differentiated gastric cells. Gene structure, promoter elements and RNA expression pattern of the lung-tissue specific Claudin-18 isoform 1 (CLDN18.1) as well, are homologous across species. These findings exemplify phylogenetic conservation of lineage-specific members of a multigene family. Given that CLDN18.2 is a novel drug target candidate, our data is also relevant for drug development as it reveals all six investigated mammalian species as suitable models for testing safety of CLDN18.2 targeting regimen.

摘要

紧密连接分子 Claudin-18 同种型 2(CLDN18.2)是人类 Claudin 紧密连接分子家族中少数严格限制在一个细胞谱系中的成员之一。本研究的目的是比较这种胃细胞特异性分子在哺乳动物中的分子结构和组织分布。我们在这里表明,CLDN18.2 蛋白序列高度保守,特别是在小鼠、大鼠、兔、狗、猴子和人类以及蜥蜴中与功能相关的结构域高度保守。此外,同源物的启动子区域高度同源,包括转录因子环腺苷酸反应元件结合蛋白(CREB)的结合位点,已知该蛋白调节人 CLDN18.2 的激活。通过 RT-PCR 和免疫组织化学,我们发现与人类基因类似,所有同源的 CLDN18.2 转录本和蛋白仅在分化的胃细胞中表达。肺组织特异性 Claudin-18 同种型 1(CLDN18.1)的基因结构、启动子元件和 RNA 表达模式在物种间也是同源的。这些发现体现了多基因家族中谱系特异性成员的系统发育保守性。鉴于 CLDN18.2 是一个新的药物靶点候选物,我们的数据对于药物开发也很重要,因为它表明所有六种被研究的哺乳动物物种都适合作为测试 CLDN18.2 靶向方案安全性的模型。

相似文献

1
Claudin-18 gene structure, regulation, and expression is evolutionary conserved in mammals.Claudin-18 基因结构、调控和表达在哺乳动物中具有进化保守性。
Gene. 2011 Aug 1;481(2):83-92. doi: 10.1016/j.gene.2011.04.007. Epub 2011 May 4.
2
claudin-18, a novel downstream target gene for the T/EBP/NKX2.1 homeodomain transcription factor, encodes lung- and stomach-specific isoforms through alternative splicing.紧密连接蛋白18是T/EBP/NKX2.1同源结构域转录因子的一个新型下游靶基因,通过可变剪接编码肺和胃特异性异构体。
Mol Cell Biol. 2001 Nov;21(21):7380-90. doi: 10.1128/MCB.21.21.7380-7390.2001.
3
Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development.Claudin-18剪接变体2是一种适用于治疗性抗体开发的泛癌靶点。
Clin Cancer Res. 2008 Dec 1;14(23):7624-34. doi: 10.1158/1078-0432.CCR-08-1547.
4
Identification of a new pebp2alphaA2 isoform from zebrafish runx2 capable of inducing osteocalcin gene expression in vitro.从斑马鱼runx2中鉴定出一种新的pebp2alphaA2亚型,其能够在体外诱导骨钙素基因表达。
J Bone Miner Res. 2005 Aug;20(8):1440-53. doi: 10.1359/JBMR.050318. Epub 2005 Mar 21.
5
Extensive expansion of the claudin gene family in the teleost fish, Fugu rubripes.硬骨鱼红鳍东方鲀中claudin基因家族的广泛扩张。
Genome Res. 2004 Jul;14(7):1248-57. doi: 10.1101/gr.2400004. Epub 2004 Jun 14.
6
Sp1 site is crucial for the mouse claudin-19 gene expression in the kidney cells.Sp1位点对于小鼠紧密连接蛋白19基因在肾细胞中的表达至关重要。
FEBS Lett. 2004 Dec 17;578(3):251-6. doi: 10.1016/j.febslet.2004.11.010.
7
Predicted expansion of the claudin multigene family.Claudin 多基因家族的预测扩张。
FEBS Lett. 2011 Feb 18;585(4):606-12. doi: 10.1016/j.febslet.2011.01.028. Epub 2011 Jan 26.
8
Transcriptional activation of the human claudin-18 gene promoter through two AP-1 motifs in PMA-stimulated MKN45 gastric cancer cells.在佛波酯(PMA)刺激的MKN45胃癌细胞中,通过两个AP-1基序实现人紧密连接蛋白18(claudin-18)基因启动子的转录激活。
Am J Physiol Gastrointest Liver Physiol. 2008 Jan;294(1):G336-43. doi: 10.1152/ajpgi.00328.2007. Epub 2007 Nov 21.
9
Comparative genomics of the Hlx homeobox gene and protein: conservation of structure and expression from fish to mammals.Hlx同源盒基因与蛋白的比较基因组学:从鱼类到哺乳动物结构与表达的保守性
Gene. 2005 Jun 6;352:45-56. doi: 10.1016/j.gene.2005.03.021.
10
Chromosome localization and structure of the murine cyclin G1 gene promoter sequence.小鼠细胞周期蛋白G1基因启动子序列的染色体定位与结构
Genomics. 1997 Oct 15;45(2):297-303. doi: 10.1006/geno.1997.4947.

引用本文的文献

1
Claudin18.2 defines a prognostically distinct subgroup of intrahepatic cholangiocarcinoma via CD8 T-cell exclusion.Claudin18.2通过CD8 T细胞排除作用定义了肝内胆管癌预后不同的亚组。
Front Oncol. 2025 Aug 29;15:1636367. doi: 10.3389/fonc.2025.1636367. eCollection 2025.
2
Claudin18.2 as a Promising Therapeutic Target in Gastric Cancer.Claudin18.2作为胃癌中一个有前景的治疗靶点。
Cells. 2025 Aug 19;14(16):1285. doi: 10.3390/cells14161285.
3
Claudin-18.2 immunohistochemical evaluation in pancreatic cancer specimens: review and recommendations for routine testing and scoring.
胰腺癌标本中Claudin-18.2的免疫组化评估:常规检测与评分的综述及建议
Virchows Arch. 2025 Aug 21. doi: 10.1007/s00428-025-04222-2.
4
Correlation of CLDN18.2 and Tumor Microenvironment in Gastric Cancer: A Systematic Review.CLDN18.2与胃癌肿瘤微环境的相关性:一项系统评价
Cancers (Basel). 2025 Jun 24;17(13):2120. doi: 10.3390/cancers17132120.
5
The challenges and progress of CAR-T cell therapy in the treatment of solid tumors.嵌合抗原受体T细胞(CAR-T)疗法在实体瘤治疗中的挑战与进展
Mol Cell Biochem. 2025 Jun 23. doi: 10.1007/s11010-025-05329-5.
6
Claudin 18.2 Expression in Gastric Tumors and Other Tumor Types With Gastric Epithelium-like Differentiation.Claudin 18.2在胃肿瘤及其他具有胃上皮样分化的肿瘤类型中的表达
In Vivo. 2025 May-Jun;39(3):1540-1553. doi: 10.21873/invivo.13954.
7
CLDN18.2: a potential nanotherapeutic target for cholangiocarcinoma.紧密连接蛋白18.2:胆管癌潜在的纳米治疗靶点
Front Pharmacol. 2025 Mar 26;16:1559558. doi: 10.3389/fphar.2025.1559558. eCollection 2025.
8
CAR-γδ T Cells Targeting Claudin18.2 Show Superior Cytotoxicity Against Solid Tumor Compared to Traditional CAR-αβ T Cells.与传统的嵌合抗原受体αβ(CAR-αβ)T细胞相比,靶向Claudin18.2的嵌合抗原受体γδ(CAR-γδ)T细胞对实体瘤显示出更强的细胞毒性。
Cancers (Basel). 2025 Mar 17;17(6):998. doi: 10.3390/cancers17060998.
9
Identification of CD66c as a potential target in gastroesophageal junction cancer for antibody-drug conjugate development.鉴定CD66c作为胃食管交界癌中抗体药物偶联物开发的潜在靶点。
Gastric Cancer. 2025 May;28(3):422-441. doi: 10.1007/s10120-025-01584-z. Epub 2025 Feb 7.
10
Pan-cancer analysis of CLDN18.2 shed new insights on the targeted therapy of upper gastrointestinal tract cancers.紧密连接蛋白18.2(CLDN18.2)的泛癌分析为上消化道癌症的靶向治疗提供了新见解。
Front Pharmacol. 2024 Nov 1;15:1494131. doi: 10.3389/fphar.2024.1494131. eCollection 2024.